Protein Kinase Inhibitors: all 15,278 studies that test it

Page 67 of 153. Open to participants first (2,556), then studies with results posted, then the rest; newest registration first within each.

• Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate CancerCompletedNCT00454571Phase 2Results posted
• Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine CancerCompletedNCT00454363Phase 2Results posted
• Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00454194Phase 2Results posted
• Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal CancerCompletedNCT00454142Phase 2Results posted
• A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in PatientsCompletedNCT00454116Phase 2Results posted
• Sunitinib in Refractory Adrenocortical CarcinomaCompletedNCT00453895Phase 2Results posted
• A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With ErlotinibCompletedNCT00453362Phase 1/2Results posted
• Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to TreatmentCompletedNCT00453310Phase 2Results posted
• Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00453154Phase 1/2Results posted
• Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast CancerCompletedNCT00452673Phase 1Results posted
• A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung CancerCompletedNCT00452413Phase 1/2Results posted
• Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)TerminatedNCT00452387Phase 2Results posted
• Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast CancerCompletedNCT00451555Phase 2Results posted
• A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP OnlyCompletedNCT00451178Phase 2Results posted
• Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaCompletedNCT00451048Phase 2Results posted
• Everolimus (RAD001) as Therapy for Patients With Systemic MastocytosisCompletedNCT00449748Phase 2Results posted
• A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00449033Phase 3Results posted
• Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck CancerTerminatedNCT00448240Phase 2/3Results posted
• BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary CancerTerminatedNCT00447122Phase 1Results posted
• Study Of AG-013736 (Axitinib) In Patients With Advanced Solid TumorsCompletedNCT00447005Phase 1Results posted
• Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFRCompletedNCT00446225Phase 3Results posted
• Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell LymphomaCompletedNCT00446095Phase 1/2Results posted
• S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung CancerCompletedNCT00445848Phase 2Results posted
• Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma MultiformeCompletedNCT00445588Phase 2Results posted
• Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal CancerTerminatedNCT00445549Phase 2Results posted
• A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast CancerCompletedNCT00445458Phase 1/2Results posted
• Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell LymphomaCompletedNCT00445341Phase 1/2Results posted
• Lapatinib and Bevacizumab for Metastatic Breast CancerCompletedNCT00444535Phase 2Results posted
• A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.CompletedNCT00443534Not applicableResults posted
• Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal JunctionTerminatedNCT00442507Phase 2Results posted
• Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain TumorsCompletedNCT00441142Phase 1/2Results posted
• Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate CancerCompletedNCT00439270Phase 1/2Results posted
• Dasatinib in Relapsed Chronic Lymphocytic LeukemiaCompletedNCT00438854Phase 2Results posted
• Enzastaurin in Combination of Capecitabine to Treat Breast CancerTerminatedNCT00437294Phase 2Results posted
• A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal CancerCompletedNCT00437268Phase 2Results posted
• PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With GemcitabineTerminatedNCT00437203Phase 1Results posted
• AZD2171 to Treat Prostate CancerCompletedNCT00436956Phase 2Results posted
• Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or CarboplatinCompletedNCT00436644Phase 2Results posted
• Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous TreatmentCompletedNCT00436618Phase 2Results posted
• Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV MelanomaCompletedNCT00436605Phase 2Results posted
• S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar CarcinomaCompletedNCT00436332Phase 2Results posted
• Chemotherapy for Participants With LymphomaCompletedNCT00436280Phase 2Results posted
• Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal CancerCompletedNCT00436215Phase 2Results posted
• A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast CancerCompletedNCT00435409Phase 3Results posted
• A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)TerminatedNCT00434356Phase 2Results posted
• A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)TerminatedNCT00434226Phase 2Results posted
• Phase II Study of Sunitinib Malate Following Hepatic Artery EmbolizationCompletedNCT00434109Phase 2Results posted
• Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab TherapyCompletedNCT00431067Phase 2Results posted
• Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical CancerCompletedNCT00430781Phase 2Results posted
• A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple MyelomaCompletedNCT00429949Phase 2Results posted
• Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00429793Phase 2Results posted
• Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast CancerCompletedNCT00429299Phase 2Results posted
• Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and ChemotherapyCompletedNCT00428714Phase 2Results posted
• A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell TumorsTerminatedNCT00428597Phase 3Results posted
• A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.CompletedNCT00428220Not applicableResults posted
• Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate CancerCompletedNCT00427999Phase 2Results posted
• AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver CancerTerminatedNCT00427973Phase 2Results posted
• AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsCompletedNCT00427349Phase 2Results posted
• Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast CancerCompletedNCT00426556Phase 1Results posted
• An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast CancerCompletedNCT00425854Phase 2Results posted
• Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney CancerCompletedNCT00425386Phase 2Results posted
• Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance.CompletedNCT00425308Phase 3Results posted
• Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid TumorsCompletedNCT00424632Phase 1Results posted
• Imatinib in Patients With Mucosal or Acral/Lentiginous MelanomaCompletedNCT00424515Phase 2Results posted
• Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)CompletedNCT00424385Phase 1Results posted
• Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After SurgeryCompletedNCT00424255Phase 3Results posted
• Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or GliosarcomaCompletedNCT00423735Phase 2Results posted
• Cediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell CarcinomaCompletedNCT00423332Phase 2Results posted
• Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast CancerCompletedNCT00422903Phase 2Results posted
• Perifosine in Patients With Relapsed/Refractory Waldenstrom's MacroglobulinemiaCompletedNCT00422656Phase 2Results posted
• Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal CancerCompletedNCT00420381Phase 2Results posted
• An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma.CompletedNCT00420056Phase 1Results posted
• Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and ChemotherapyCompletedNCT00419159Phase 2Results posted
• Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC PatientsCompletedNCT00418886Phase 3Results posted
• A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast CancerTerminatedNCT00417885Phase 1/2Results posted
• Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung CancerTerminatedNCT00417248Phase 1/2Results posted
• TALL-104 and Gleevec in Chronic Myelogenous Leukemia PatientsTerminatedNCT00415909Phase 2Results posted
• Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation TherapyCompletedNCT00415363Phase 2Results posted
• A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former SmokersCompletedNCT00414960Phase 2Results posted
• Efficacy and Safety of Sirolimus in LAMCompletedNCT00414648Phase 3Results posted
• Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT00414440Phase 4Results posted
• Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate CancerCompletedNCT00414388Phase 1/2Results posted
• Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid ArthritisCompletedNCT00413699Phase 3Results posted
• Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid ArthritisCompletedNCT00413660Phase 2Results posted
• BI 2536 Second Line Monotherapy in SCLCCompletedNCT00412880Phase 2Results posted
• A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell CancerTerminatedNCT00412217Phase 3Results posted
• Everolimus and Octreotide in Patients With Advanced Carcinoid TumorCompletedNCT00412061Phase 3Results posted
• A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast CancerCompletedNCT00411788Phase 2Results posted
• BATTLE Program: Sorafenib in Patients With NSCLCCompletedNCT00411671Phase 2Results posted
• BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00411632Phase 2Results posted
• Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis ComplexCompletedNCT00411619Phase 1/2Results posted
• Efficacy and Safety of Sunitinib in Metastatic Gastric CancerCompletedNCT00411151Phase 2Results posted
• AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung CancerCompletedNCT00410904Phase 2Results posted
• Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00410826Phase 2Results posted
• S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the BoneCompletedNCT00410813Phase 2Results posted
• An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid CancerCompletedNCT00410761Phase 3Results posted
• BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLCCompletedNCT00410189Phase 2Results posted
• RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or SunitinibCompletedNCT00410124Phase 3Results posted
• BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLCCompletedNCT00410059Phase 2Results posted
• RAD001 in Previously Treated Patients With Metastatic Pancreatic CancerCompletedNCT00409292Phase 2Results posted

← Protein Kinase Inhibitors overview